GB0905821D0 - Antimicrobial cyclic peptides - Google Patents

Antimicrobial cyclic peptides

Info

Publication number
GB0905821D0
GB0905821D0 GBGB0905821.5A GB0905821A GB0905821D0 GB 0905821 D0 GB0905821 D0 GB 0905821D0 GB 0905821 A GB0905821 A GB 0905821A GB 0905821 D0 GB0905821 D0 GB 0905821D0
Authority
GB
United Kingdom
Prior art keywords
cyclic peptides
antimicrobial
antimicrobial cyclic
peptides
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0905821.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Universiteit Leiden
Rijksinstituut Voor Volksgezondheid en Milieu
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Universiteit Leiden
Rijksinstituut Voor Volksgezondheid en Milieu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO, Universiteit Leiden, Rijksinstituut Voor Volksgezondheid en Milieu filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority to GBGB0905821.5A priority Critical patent/GB0905821D0/en
Publication of GB0905821D0 publication Critical patent/GB0905821D0/en
Priority to PCT/IB2010/001250 priority patent/WO2010113042A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/66—Gramicidins S, C; Tyrocidins A, B, C; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0905821.5A 2009-04-03 2009-04-03 Antimicrobial cyclic peptides Ceased GB0905821D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0905821.5A GB0905821D0 (en) 2009-04-03 2009-04-03 Antimicrobial cyclic peptides
PCT/IB2010/001250 WO2010113042A1 (en) 2009-04-03 2010-04-06 Antimicrobial cyclic peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0905821.5A GB0905821D0 (en) 2009-04-03 2009-04-03 Antimicrobial cyclic peptides

Publications (1)

Publication Number Publication Date
GB0905821D0 true GB0905821D0 (en) 2009-05-20

Family

ID=40750072

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0905821.5A Ceased GB0905821D0 (en) 2009-04-03 2009-04-03 Antimicrobial cyclic peptides

Country Status (2)

Country Link
GB (1) GB0905821D0 (en)
WO (1) WO2010113042A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013111158A2 (en) * 2012-01-03 2013-08-01 Msn Laboratories Limited Process for the preparation of dpp-iv inhibitor
CN104557582A (en) * 2015-01-04 2015-04-29 浙江工业大学 preparation method of saxagliptin intermediate
WO2023085973A1 (en) * 2021-11-15 2023-05-19 Общество С Ограниченной Ответственностью "Валента-Интеллект" Pharmacuetical compositions for treating inflammatory infectious diseases
CN118530301B (en) * 2023-12-28 2025-03-25 遵义医科大学珠海校区 A linear decapeptide derived from cyclic peptide GS and its application

Also Published As

Publication number Publication date
WO2010113042A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
GB2473090B (en) Harvester
IL214365A0 (en) Antibiotic peptides
ZA201200820B (en) N1-sulfonyl-5-fluoropyrimidinone derviatives
GB0907534D0 (en) Injection devices
GB201012651D0 (en) Peptides
EP2437770A4 (en) ANTIMICROBIAL PEPTIDES
ZA201202266B (en) Insecticidal proteins
HRP20190262T1 (en) Antimicrobial peptides based on cmap27
EP2480578A4 (en) Polypeptide modification
GB0921995D0 (en) Antimicrobial peptides
GB0920981D0 (en) Peptides
IL225495A0 (en) Antimicrobial protein
ZA201108446B (en) FViII-DERIVED PEPTIDES
GB201000352D0 (en) Antimicrobial peptides
GB0905821D0 (en) Antimicrobial cyclic peptides
ZA201203722B (en) Peptide
GB0918321D0 (en) Cyclic peptide synthesis
GB0916313D0 (en) Insecticide
GB0900924D0 (en) Instant kofta
GB201017284D0 (en) Antimicrobial protein
TWM389494U (en) Incense
SG2014013296A (en) Antimicrobial peptides
GB0911790D0 (en) Peptides
IL214496A0 (en) Short b-defensin-derived peptides
AU4021P (en) Moonbi Glycine max

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)